{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:22:00Z","timestamp":1785522120868,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10616-y","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:25:50Z","timestamp":1783769150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Von Willebrand factor A1 blockade prevents platelet-mediated sustained occlusion for the treatment of arterial thrombosis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-1078","authenticated-orcid":false,"given":"Emily P.","family":"Mihalko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1940-4247","authenticated-orcid":false,"given":"Blake","family":"Holthaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rassam M. G.","family":"Rassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid M.","family":"Nimjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-2747","authenticated-orcid":false,"given":"Susan M.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"10616_CR1","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob, G. E. et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb. Vasc. Biol. 34, 2363\u20132371 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10616_CR2","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). WHO Fact Sheets (World Health Organization, 2025). Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (accessed June 11, 2025)."},{"key":"10616_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00004872-200306005-00002","volume":"21","author":"HPJ Adams","year":"2003","unstructured":"Adams, H. P. J. Stroke: a vascular pathology with inadequate management. J. Hypertens. 21, S3 (2003).","journal-title":"J. Hypertens."},{"key":"10616_CR4","first-page":"143","volume":"36","author":"T Ingall","year":"2004","unstructured":"Ingall, T. Stroke-incidence, mortality, morbidity and risk. J. Insur Med. 36, 143\u2013152 (2004).","journal-title":"J. Insur Med."},{"key":"10616_CR5","first-page":"S36","volume":"15","author":"DM Kolansky","year":"2009","unstructured":"Kolansky, D. M. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am. J. Manag Care. 15, S36\u2013S41 (2009).","journal-title":"Am. J. Manag Care."},{"key":"10616_CR6","doi-asserted-by":"crossref","unstructured":"Taylor, T. N. et al. Lifetime cost of stroke in the United States. Stroke 27, 1459\u20131466 (1996).","DOI":"10.1161\/01.STR.27.9.1459"},{"key":"10616_CR7","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1161\/STROKEAHA.109.552547","volume":"40","author":"MG Lansberg","year":"2009","unstructured":"Lansberg, M. G., Bluhmki, E. & Thijs, V. N. Efficacy and safety of tissue plasminogen activator 3 to 4.5\u2009h after acute ischemic stroke. Stroke 40, 2438\u20132441 (2009).","journal-title":"Stroke"},{"key":"10616_CR8","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao, S. V. et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation 151, e771\u2013e862 (2025).","journal-title":"Circulation"},{"key":"10616_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5853\/jos.2016.01515","volume":"19","author":"ID Pe\u00f1a","year":"2017","unstructured":"Pe\u00f1a, I. D., Borlongan, C., Shen, G. & Davis, W. Strategies to extend thrombolytic time window for ischemic stroke treatment: an unmet clinical need. J. Stroke 19, 50\u201360 (2017).","journal-title":"J. Stroke"},{"key":"10616_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","volume":"28","author":"The NINDS t-PA Stroke Study Group","year":"1997","unstructured":"NINDS t-PA Stroke Study Group, T. he Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28, 2109\u20132118 (1997).","journal-title":"Stroke"},{"key":"10616_CR11","doi-asserted-by":"publisher","unstructured":"Ma\u00efer, B., Desilles, J. P., Mazighi, M. Intracranial hemorrhage after reperfusion therapies in acute ischemic stroke patients. Front Neurol. 11. https:\/\/doi.org\/10.3389\/fneur.2020.599908 (2020).","DOI":"10.3389\/fneur.2020.599908"},{"key":"10616_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","volume":"41","author":"P Tanswell","year":"2002","unstructured":"Tanswell, P., Modi, N., Combs, D. & Danays, T. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin. Pharmacokinet. 41, 1229\u20131245 (2002).","journal-title":"Clin. Pharmacokinet."},{"key":"10616_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","volume":"401","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. Lancet 401, 645\u2013654 (2023).","journal-title":"Lancet"},{"key":"10616_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/2396987316667176","volume":"1","author":"SE Tawil","year":"2016","unstructured":"Tawil, S. E. et al. How many stroke patients might be eligible for mechanical thrombectomy? Eur. Stroke J. 1, 264\u2013271 (2016).","journal-title":"Eur. Stroke J."},{"key":"10616_CR15","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723\u20131731 (2016).","journal-title":"Lancet"},{"key":"10616_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59526-x","volume":"10","author":"IN Chernysh","year":"2020","unstructured":"Chernysh, I. N. et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci. Rep. 10, 5112 (2020).","journal-title":"Sci. Rep."},{"key":"10616_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2023.12.010","volume":"550","author":"S Vandelanotte","year":"2024","unstructured":"Vandelanotte, S. & De Meyer, S. F. Acute ischemic stroke thrombus composition. Neuroscience 550, 11\u201320 (2024).","journal-title":"Neuroscience"},{"key":"10616_CR18","doi-asserted-by":"publisher","first-page":"e1686","DOI":"10.1212\/WNL.0000000000008395","volume":"93","author":"L Di Meglio","year":"2019","unstructured":"Di Meglio, L. et al. Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis. Neurology 93, e1686\u2013e1698 (2019).","journal-title":"Neurology"},{"key":"10616_CR19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jvs.2014.12.050","volume":"61","author":"LDC Casa","year":"2015","unstructured":"Casa, L. D. C., Deaton, D. H. & Ku, D. N. Role of high shear rate in thrombosis. J. Vasc. Surg. 61, 1068\u20131080 (2015).","journal-title":"J. Vasc. Surg."},{"key":"10616_CR20","doi-asserted-by":"crossref","unstructured":"Reininger, A. J. et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107, 3537\u20133545 (2006).","DOI":"10.1182\/blood-2005-02-0618"},{"key":"10616_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/neurintsurg-2022-018645","volume":"15","author":"OM Mereuta","year":"2023","unstructured":"Mereuta, O. M. et al. Correlation of von Willebrand factor and platelets with acute ischemic stroke etiology and revascularization outcome: an immunohistochemical study. J. Neurointerv Surg. 15, 488\u2013494 (2023).","journal-title":"J. Neurointerv Surg."},{"key":"10616_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1161\/STROKEAHA.120.032810","volume":"52","author":"P Jolugbo","year":"2021","unstructured":"Jolugbo, P. & Ari\u00ebns, R. A. S. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke 52, 1131\u20131142 (2021).","journal-title":"Stroke"},{"key":"10616_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13231-014-0014-y","volume":"7","author":"AJ Tomkins","year":"2015","unstructured":"Tomkins, A. J. et al. Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke. Exp. Transl. Stroke Med. 7, 2 (2015).","journal-title":"Exp. Transl. Stroke Med."},{"key":"10616_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1182\/blood-2014-09-599530","volume":"127","author":"DW Chung","year":"2016","unstructured":"Chung, D. W. et al. High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion. Blood 127, 637\u2013645 (2016).","journal-title":"Blood"},{"key":"10616_CR25","doi-asserted-by":"publisher","unstructured":"Liu, J. S. T., Ding, Y., Schoenwaelder, S., Liu, X. Improving treatment for acute ischemic stroke\u2014Clot busting innovation in the pipeline. Front. Med. Technol. 4. https:\/\/doi.org\/10.3389\/fmedt.2022.946367 (2022).","DOI":"10.3389\/fmedt.2022.946367"},{"key":"10616_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1053\/j.seminhematol.2004.09.006","volume":"42","author":"GL Mendolicchio","year":"2005","unstructured":"Mendolicchio, G. L. & Ruggeri, Z. M. New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol. 42, 5\u201314 (2005).","journal-title":"Semin Hematol."},{"key":"10616_CR27","first-page":"319","volume":"52","author":"S Gogia","year":"2015","unstructured":"Gogia, S. & Neelamegham, S. Role of fluid shear stress in regulating VWF structure, function and related blood disorders. Biorheology 52, 319\u2013335 (2015).","journal-title":"Biorheology"},{"key":"10616_CR28","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1529\/biophysj.107.128520","volume":"95","author":"NA Mody","year":"2008","unstructured":"Mody, N. A. & King, M. R. Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIb\u03b1-vWF-GPIb\u03b1 bridging. Biophys. J. 95, 2556\u20132574 (2008).","journal-title":"Biophys. J."},{"key":"10616_CR29","doi-asserted-by":"crossref","unstructured":"Machenaud, E. L. V. et al. Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation. Blood Adv. 9, 6019\u20136030 (2025).","DOI":"10.1182\/bloodadvances.2025017354"},{"key":"10616_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ymthe.2019.03.016","volume":"27","author":"SM Nimjee","year":"2019","unstructured":"Nimjee, S. M. et al. Preclinical development of a vWF aptamer to limit thrombosis and engender arterial recanalization of occluded vessels. Mol. Ther. 27, 1228\u20131241 (2019).","journal-title":"Mol. Ther."},{"key":"10616_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ph15121450","volume":"15","author":"SM Shea","year":"2022","unstructured":"Shea, S. M. et al. Dose-dependent Von Willebrand factor inhibition by aptamer BB-031 correlates with thrombolysis in a microfluidic model of arterial occlusion. Pharmaceuticals 15, 1450 (2022).","journal-title":"Pharmaceuticals"},{"key":"10616_CR32","doi-asserted-by":"crossref","unstructured":"Behot, A. L. et al. GpIba-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice. Blood 123, 3354\u20133363 (2014).","DOI":"10.1182\/blood-2013-12-543074"},{"key":"10616_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1160\/TH12-01-0046","volume":"108","author":"M Crescente","year":"2012","unstructured":"Crescente, M. et al. ADAMTS13 exerts a thrombolytic effect in microcirculation. Thromb. Haemost. 108, 527\u2013532 (2012).","journal-title":"Thromb. Haemost."},{"key":"10616_CR34","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1182\/blood.2021012787","volume":"139","author":"K South","year":"2022","unstructured":"South, K. et al. Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models. Blood 139, 1575\u20131587 (2022).","journal-title":"Blood"},{"key":"10616_CR35","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1182\/blood.2022016342","volume":"140","author":"MVA Van Moorsel","year":"2022","unstructured":"Van Moorsel, M. V. A. et al. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models. Blood 140, 2844\u20132848 (2022).","journal-title":"Blood"},{"key":"10616_CR36","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.rpth.2022.100023","volume":"7","author":"RI Litvinov","year":"2023","unstructured":"Litvinov, R. I. & Weisel, J. W. Blood clot contraction: mechanisms, pathophysiology, and disease. Res. Pract. Thrombosis Haemost. 7, 100023 (2023).","journal-title":"Res. Pract. Thrombosis Haemost."},{"key":"10616_CR37","first-page":"198","volume":"155","author":"RG Painter","year":"1984","unstructured":"Painter, R. G. & Ginsberg, M. H. Centripetal myosin redistribution in thrombin-stimulated platelets. Relatsh. Platelet Factor 4 Secret. Exp. Cell Res. 155, 198\u2013212 (1984).","journal-title":"Relatsh. Platelet Factor 4 Secret. Exp. Cell Res."},{"key":"10616_CR38","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2006-04-011551","volume":"108","author":"ZM Ruggeri","year":"2006","unstructured":"Ruggeri, Z. M., Orje, J. N., Habermann, R., Federici, A. B. & Reininger, A. J. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 108, 1903\u20131910 (2006).","journal-title":"Blood"},{"key":"10616_CR39","doi-asserted-by":"crossref","unstructured":"Chiasakul, T. & Kenneth, A. B. Thrombolytic therapy in acute venous thromboembolism. Hematology Am Soc Hematol Educ Program. 4, 612\u2013618 (2020).","DOI":"10.1182\/hematology.2020000148"},{"key":"10616_CR40","doi-asserted-by":"crossref","unstructured":"Casa, L. D. C. & Ku, D. N. Geometric design of microfluidic chambers: platelet adhesion versus accumulation. Biomed. Microdevices. 16, 115\u2013126 (2014).","DOI":"10.1007\/s10544-013-9811-7"},{"key":"10616_CR41","doi-asserted-by":"crossref","unstructured":"Casa, L. D. C., Gillespie, S. E., Meeks S. L. & Ku, D. N. Relative Contributions of von Willebrand Factor and Platelets in High Shear Thrombosis. J. Hematol Thrombo Dis. 4, 1000249 (2016).","DOI":"10.4172\/2329-8790.1000249"},{"key":"10616_CR42","doi-asserted-by":"crossref","unstructured":"Mihalko, E. et al. Microfluidics in Assessing Platelt Function. J. Vis Exp. 8, 10.3791\/67214 (2024).","DOI":"10.3791\/67214"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10616-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:11:52Z","timestamp":1785517912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10616-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10616"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10616-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M.N. is founder and CMO of Basking Biosciences. Basking Biosciences provided a portion of funding for this study to S.M.S. at University of Pittsburgh, and also provided BB-031 material for the study. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1024"}}